Evidence map›Paper›PMID 35637928›Full record

ArticleInfection and drug resistance2022

Impact of the

Irma Olarte Carrillo, Christian Omar Ramos Peñafiel, Iveth Mendoza Salas, Rafael Cerón Maldonado, Anel Irais García Laguna, Adrián De la Cruz Rosas, Carlos Martinez Murrillo, Adolfo Martinez Tovar

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Irma Olarte CarrilloLaboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0002-5374-0534
Christian Omar Ramos PeñafielServicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0003-0957-9090
Iveth Mendoza SalasServicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0003-0534-0891
Rafael Cerón MaldonadoLaboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0003-0935-4107
Anel Irais García LagunaLaboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0002-5308-1292
Adrián De la Cruz RosasLaboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0001-7137-4059
Carlos Martinez MurrilloServicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0002-9950-0472
Adolfo Martinez TovarLaboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, "Dr. Eduardo Liceaga", Ciudad de México, Mexico.ORCID 0000-0002-5713-3731
Hospital General de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: In the last two years progress was made in molecular, physio pathological understanding and the form of transmission of COVID-19, and different therapeutic strategies have been explored to deal with the situation of the pandemic. However, the evaluation of certain genes that participate in the metabolism and transport of these drugs has not been fully explored. A lack of response to treatment and a lower survival have been observed that may be due to the presence of the Methods: The expression levels of the Results: The different risk variables showed that patients with either high or absent levels of Conclusion: High levels or null expression of the

Indexed as

ABCB1drug transporter genesSARS-CoV2

Identifiers

PMID35637928
PMCPMC9147417
OpenAlexW4281383051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.